Last checked at 2 Jan 2020 15:57
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades5,587
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,651.00
Bid:
1,651.00
Ask:
1,652.00
Change:
11.50 (0.70%)
Spread:
1.00 (0.061%)
Open:
1,650.50
High:
1,656.00
Low:
1,637.00
Prev. Close:
1,639.50
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.1 Jan 2020 16:09
More drugmakers hike U.S. prices as new year begins
By Michael ErmanNEW YORK, Jan 1 (Reuters) - Drugmakers including Bristol-Myers Squibb Co, Gilead Sciences Inc, and Biogen Inc hiked U.S. list prices on more than 50 drugs on Wednesday, bringing total New Year's Day drug price increases to more th...
Read more31 Dec 2019 13:29
GlaxoSmithKline Completes EUR955 Million Sale Of Travel Vaccines
GlaxoSmithKline Completes EUR955 Million Sale Of Travel Vaccines
Read more31 Dec 2019 10:59
CORRECTED-UPDATE 1-China approves home-grown vaccines, offering alternative to global drugmakers' products
(Corrects DEC 31 story to show GSK did not participate in the development of Cecolin, paragraphs 6-7)BEIJING, Dec 31 (Reuters) - China has approved a pneumonia vaccine developed by Chinese drugmaker Walvax Biotechnology's unit, its National Medica...
Read more31 Dec 2019 10:59
UPDATE 1-China approves home-grown vaccines, offering alternative to global drugmakers' products
(Adds HPV vaccine approval in 6th and 7th paragraphs, adds background on new pneumonia case in 5th paragraph,)BEIJING, Dec 31 (Reuters) - China has approved a pneumonia vaccine developed by Chinese drugmaker Walvax Biotechnology's unit, its Nation...
Read more30 Dec 2019 09:16
UPDATE 2-Profit-taking puts brakes on UK stock rally
* FTSE 100 down 0.8%, FTSE 250 down 0.6%* Healthcare firms, oil stocks drag on main index* NMC Health outperforms blue-chips (Adds news items, updates to closing prices)By Shashwat AwasthiDec 30 (Reuters) - British shares fell on the year's penulti...
Read more30 Dec 2019 08:02
UPDATE 2-AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer
* First of its kind to get FDA okay to treat pancreatic cancer* Lynparza belongs to class of treatments called PARP inhibitors* Drug had sales of $847 mln in 9 months to September (Recasts, adds details, executive comment)By Pushkala AripakaDec 30...
Read more23 Dec 2019 10:40
UK WINNERS & LOSERS SUMMARY: NMC Surges On Plan For Independent Review
UK WINNERS & LOSERS SUMMARY: NMC Surges On Plan For Independent Review
Read more23 Dec 2019 07:40
FDA issues CRL to ViiV Healthcare for cabotegravir and rilpivirine HIV regimen
(Sharecast News) - America's health regulator issued a response at the start of the week to GlaxoSmithKline's application for an HIV-1 treatment for virologically suppressed adults from its ViiV Healthcare subsidiary.
Read more21 Dec 2019 11:40
US FDA Rejects New Drug Application For ViiV Healthcare HIV Treatment
US FDA Rejects New Drug Application For ViiV Healthcare HIV Treatment
Read more21 Dec 2019 10:29
U.S. FDA declines to approve GSK drugs division's long acting HIV injection
Dec 21 (Reuters) - GlaxoSmithKline's HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.ViiV, in which Pfizer and Shionogi have small stakes, said it re...
Read more20 Dec 2019 12:28
Friday broker round-up
(Sharecast News) - Segro: HSBC downgrades to hold with a target price of 869p.
Read more18 Dec 2019 15:49
GlaxoSmithKline Pleased With Benlysta Phase 3 Test Results
GlaxoSmithKline Pleased With Benlysta Phase 3 Test Results
Read more13 Dec 2019 08:49
UPDATE 4-UK Plc shares hail Johnson's storming election victory
* FTSE 100 up 1.1%, FTSE 250 jumps 3.3%* Homebuilders among top risers* Utilities soar as Corbyn says to step down as Labour leader* RBS, Lloyds jump (Adds closing prices)By Thyagaraju Adinarayan and Julien PonthusLONDON, Dec 13 (Reuters) - UK shar...
Read more13 Dec 2019 08:49
UPDATE 3-UK Plc shares hail Johnson's storming general election victory
* FTSE 100 up 1.8%, FTSE 250 jumps 4.2%* Banks and retailers among top risers* Utilities soar as Corbyn steps down as Labour leader* National Grid, United Utilities up 5%* RBS, Lloyds jump more than 10% (Adds volume statistics)By Thyagaraju Adinaray...
Read more